Park Place Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Park Place Capital's PFE Position: Q3 2026 in Review
Park Place Capital increased its Pfizer (PFE) stake by 13% in Q3 2026, buying an estimated $105K and bringing the position to 34,749 shares worth $991K. The position accounts for 0.37% of the portfolio, ranked #58.
Park Place Capital first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.64M in Q3 2025. 2,905 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Park Place Capital held 34,749 shares of Pfizer worth $991K as of Q3 2026.
- Park Place Capital bought 3,957 Pfizer shares in Q3 2026, an estimated $105K.
- Pfizer made up 0.37% of Park Place Capital's portfolio in Q3 2026, its #58 holding.
- Park Place Capital first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
- Park Place Capital's Pfizer position peaked at $1.64M in Q3 2025.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Park Place Capital's 13F filing for Q3 2026, filed 9 Nov 2026.